Healthcare Co.,Ltd. (SHA:603313)
China · Delayed Price · Currency is CNY 6.42
-0.56 (-8.02%)
Apr 30, 2026, 3:00 PM CST
Healthcare Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 9,120 | 8,912 | 8,232 | 7,759 | 7,786 | 7,912 |
Other Revenue | - | - | 217.37 | 217.21 | 231.56 | 227.36 |
| 9,120 | 8,912 | 8,449 | 7,976 | 8,017 | 8,139 | |
Revenue Growth (YoY) | 5.15% | 5.48% | 5.94% | -0.52% | -1.50% | 24.64% |
Cost of Revenue | 5,555 | 5,412 | 5,357 | 4,948 | 5,547 | 5,876 |
Gross Profit | 3,565 | 3,500 | 3,092 | 3,028 | 2,471 | 2,263 |
Selling, General & Admin | 3,013 | 2,910 | 2,526 | 2,300 | 2,032 | 1,947 |
Research & Development | 135.3 | 136.81 | 141.51 | 115.66 | 95.31 | 124.25 |
Other Operating Expenses | 30.57 | 27.89 | 42.42 | 47.41 | 46.53 | 30.38 |
Operating Expenses | 3,179 | 3,075 | 3,084 | 2,545 | 2,213 | 2,157 |
Operating Income | 386.73 | 425.45 | 7.91 | 482.9 | 257.36 | 106.66 |
Interest Expense | - | - | -181.99 | -214.03 | -182.32 | -140.52 |
Interest & Investment Income | 0.59 | - | 11.75 | 3.63 | 50.88 | 21.29 |
Currency Exchange Gain (Loss) | - | - | 23.92 | 33.61 | 120.64 | -72.14 |
Other Non Operating Income (Expenses) | -345.68 | -290.34 | -14.34 | -139.43 | -124.37 | -149.75 |
EBT Excluding Unusual Items | 41.65 | 135.11 | -152.75 | 166.68 | 122.2 | -234.45 |
Impairment of Goodwill | - | - | -37.57 | -9.53 | -2.24 | -0.46 |
Gain (Loss) on Sale of Investments | 7.25 | 7.69 | -7.93 | -12.5 | -29 | 4.52 |
Gain (Loss) on Sale of Assets | -2.66 | -0.51 | 15.74 | -0.04 | -2.88 | -4.8 |
Asset Writedown | -99.73 | -92.5 | - | -4.23 | - | - |
Legal Settlements | - | - | - | - | - | -108.26 |
Other Unusual Items | - | - | 17.52 | 24.02 | -6.71 | 69.13 |
Pretax Income | -53.49 | 49.79 | -164.25 | 164.47 | 81.37 | -274.16 |
Income Tax Expense | 58.54 | 70.28 | 14.71 | 42.93 | 29.4 | -4.53 |
Earnings From Continuing Operations | -112.03 | -20.49 | -178.96 | 121.54 | 51.97 | -269.64 |
Minority Interest in Earnings | 5.38 | 10.67 | 27.54 | -14.94 | -10.61 | -5.89 |
Net Income | -106.65 | -9.82 | -151.42 | 106.6 | 41.36 | -275.53 |
Net Income to Common | -106.65 | -9.82 | -151.42 | 106.6 | 41.36 | -275.53 |
Net Income Growth | - | - | - | 157.74% | - | - |
Shares Outstanding (Basic) | 480 | 491 | 561 | 485 | 460 | 483 |
Shares Outstanding (Diluted) | 480 | 491 | 561 | 485 | 460 | 483 |
Shares Change (YoY) | -11.43% | -12.43% | 15.74% | 5.44% | -4.93% | 8.04% |
EPS (Basic) | -0.22 | -0.02 | -0.27 | 0.22 | 0.09 | -0.57 |
EPS (Diluted) | -0.22 | -0.02 | -0.27 | 0.22 | 0.09 | -0.57 |
EPS Growth | - | - | - | 144.44% | - | - |
Free Cash Flow | 511.8 | 496.82 | 584.57 | 502.1 | -65.68 | -471.52 |
Free Cash Flow Per Share | 1.06 | 1.01 | 1.04 | 1.04 | -0.14 | -0.97 |
Dividend Per Share | - | - | 0.050 | - | - | - |
Gross Margin | 39.09% | 39.28% | 36.60% | 37.96% | 30.82% | 27.81% |
Operating Margin | 4.24% | 4.77% | 0.09% | 6.05% | 3.21% | 1.31% |
Profit Margin | -1.17% | -0.11% | -1.79% | 1.34% | 0.52% | -3.38% |
Free Cash Flow Margin | 5.61% | 5.58% | 6.92% | 6.30% | -0.82% | -5.79% |
EBITDA | 948.79 | 983.5 | 549.94 | 988.58 | 493.78 | 295.53 |
EBITDA Margin | 10.40% | 11.04% | 6.51% | 12.39% | 6.16% | 3.63% |
D&A For EBITDA | 562.06 | 558.05 | 542.03 | 505.67 | 236.42 | 188.86 |
EBIT | 386.73 | 425.45 | 7.91 | 482.9 | 257.36 | 106.66 |
EBIT Margin | 4.24% | 4.77% | 0.09% | 6.05% | 3.21% | 1.31% |
Effective Tax Rate | - | 141.15% | - | 26.10% | 36.13% | - |
Revenue as Reported | - | - | 8,449 | 7,976 | 8,017 | 8,139 |
Advertising Expenses | - | - | 281.14 | 227.4 | 190.11 | 196.31 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.